JP2023512442A5 - - Google Patents
Info
- Publication number
- JP2023512442A5 JP2023512442A5 JP2022542486A JP2022542486A JP2023512442A5 JP 2023512442 A5 JP2023512442 A5 JP 2023512442A5 JP 2022542486 A JP2022542486 A JP 2022542486A JP 2022542486 A JP2022542486 A JP 2022542486A JP 2023512442 A5 JP2023512442 A5 JP 2023512442A5
- Authority
- JP
- Japan
- Prior art keywords
- cdr
- seq
- complex according
- complex
- oligonucleotide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (13)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062959788P | 2020-01-10 | 2020-01-10 | |
| US62/959,788 | 2020-01-10 | ||
| US202062965740P | 2020-01-24 | 2020-01-24 | |
| US62/965,740 | 2020-01-24 | ||
| US202062968761P | 2020-01-31 | 2020-01-31 | |
| US62/968,761 | 2020-01-31 | ||
| US202063055513P | 2020-07-23 | 2020-07-23 | |
| US63/055,513 | 2020-07-23 | ||
| US202063061833P | 2020-08-06 | 2020-08-06 | |
| US63/061,833 | 2020-08-06 | ||
| US202063132929P | 2020-12-31 | 2020-12-31 | |
| US63/132,929 | 2020-12-31 | ||
| PCT/US2021/012719 WO2021142275A1 (en) | 2020-01-10 | 2021-01-08 | Muscle targeting complexes and uses thereof for treating facioscapulohumeral muscular dystrophy |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023512442A JP2023512442A (ja) | 2023-03-27 |
| JP2023512442A5 true JP2023512442A5 (cg-RX-API-DMAC7.html) | 2024-01-17 |
| JP7894315B2 JP7894315B2 (ja) | 2026-07-23 |
Family
ID=76788742
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022542486A Active JP7894315B2 (ja) | 2020-01-10 | 2021-01-08 | 顔面肩甲上腕型筋ジストロフィーを処置するための筋標的化複合体およびそれらの使用 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20230088865A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4087924A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7894315B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR20220125801A (cg-RX-API-DMAC7.html) |
| CN (2) | CN122124274A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2021205492A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112022013603A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3163299A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL294480A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2022008538A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2021142275A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12370264B1 (en) | 2018-08-02 | 2025-07-29 | Dyne Therapeutics, Inc. | Complexes comprising an anti-transferrin receptor antibody linked to an oligonucleotide and method of delivering oligonucleotide to a subject |
| US12097263B2 (en) | 2018-08-02 | 2024-09-24 | Dyne Therapeutics, Inc. | Muscle targeting complexes and uses thereof for treating myotonic dystrophy |
| US12018087B2 (en) | 2018-08-02 | 2024-06-25 | Dyne Therapeutics, Inc. | Muscle-targeting complexes comprising an anti-transferrin receptor antibody linked to an oligonucleotide and methods of delivering oligonucleotide to a subject |
| EP3830259A4 (en) | 2018-08-02 | 2022-05-04 | Dyne Therapeutics, Inc. | MUSCLE TARGETED COMPLEXES AND THEIR USES IN THE TREATMENT OF FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY |
| US11911484B2 (en) | 2018-08-02 | 2024-02-27 | Dyne Therapeutics, Inc. | Muscle targeting complexes and uses thereof for treating myotonic dystrophy |
| US11168141B2 (en) | 2018-08-02 | 2021-11-09 | Dyne Therapeutics, Inc. | Muscle targeting complexes and uses thereof for treating dystrophinopathies |
| WO2020028832A1 (en) | 2018-08-02 | 2020-02-06 | Dyne Therapeutics, Inc. | Muscle targeting complexes and uses thereof for treating dystrophinopathies |
| US20230111212A1 (en) * | 2020-01-10 | 2023-04-13 | Dyne Therapeutics, Inc. | Muscle targeting complexes and uses thereof for treating dystrophinopathies |
| EP4087653A4 (en) * | 2020-01-10 | 2024-06-19 | Dyne Therapeutics, Inc. | Muscle targeting complexes and uses thereof for treating myotonic dystrophy |
| WO2021154477A1 (en) | 2020-01-31 | 2021-08-05 | Dyne Therapeutics, Inc. | Anti-transferrin receptor (tfr) antibody and uses thereof |
| TW202144572A (zh) | 2020-03-19 | 2021-12-01 | 美商亞維代堤生物科學公司 | 治療臉肩胛肱骨肌肉失養症之組合物及方法 |
| CN116096890A (zh) | 2020-04-02 | 2023-05-09 | 米雷楚莱股份有限公司 | 使用工程化寡核苷酸的靶向抑制 |
| US11672872B2 (en) | 2021-07-09 | 2023-06-13 | Dyne Therapeutics, Inc. | Anti-transferrin receptor antibody and uses thereof |
| US11969475B2 (en) | 2021-07-09 | 2024-04-30 | Dyne Therapeutics, Inc. | Muscle targeting complexes and uses thereof for treating facioscapulohumeral muscular dystrophy |
| US11633498B2 (en) | 2021-07-09 | 2023-04-25 | Dyne Therapeutics, Inc. | Muscle targeting complexes and uses thereof for treating myotonic dystrophy |
| US11771776B2 (en) | 2021-07-09 | 2023-10-03 | Dyne Therapeutics, Inc. | Muscle targeting complexes and uses thereof for treating dystrophinopathies |
| US11638761B2 (en) | 2021-07-09 | 2023-05-02 | Dyne Therapeutics, Inc. | Muscle targeting complexes and uses thereof for treating Facioscapulohumeral muscular dystrophy |
| WO2023283623A1 (en) | 2021-07-09 | 2023-01-12 | Dyne Therapeutics, Inc. | Muscle targeting complexes and formulations for treating dystrophinopathies |
| EP4401792A4 (en) | 2021-09-16 | 2025-12-03 | Avidity Biosciences Inc | COMPOSITIONS AND METHODS OF TREATMENT OF FACIO-SCAPULO-HUMERAL MUSCULAR DYSTROPHY |
| EP4426356A1 (en) * | 2021-11-01 | 2024-09-11 | Dyne Therapeutics, Inc. | Muscle targeting complexes for treating dystrophinopathies |
| IL314093A (en) * | 2022-01-07 | 2024-09-01 | Mirecule Inc | Agents used for tissue-specific imaging and as therapeutic agents targeting proteins expressed on the surface of muscle cells |
| IL316143A (en) | 2022-04-15 | 2024-12-01 | Dyne Therapeutics Inc | Muscle targeting complexes and formulations for the treatment of myotonic dystrophy |
| KR20260044219A (ko) | 2023-07-21 | 2026-04-01 | 매로우 테라퓨틱스, 인크. | 조혈 세포 표적화 접합체 및 관련 방법 |
| US12527877B2 (en) | 2024-01-24 | 2026-01-20 | Arrowhead Pharmaceuticals, Inc. | Anti-transferrin receptor antibodies, conjugates thereof, and uses thereof |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7241444B2 (en) * | 2002-01-18 | 2007-07-10 | Pierre Fabre Medicament | Anti-IGF-IR antibodies and uses thereof |
| CA2842798C (en) * | 2011-07-25 | 2021-02-23 | Nationwide Children's Hospital, Inc. | Recombinant virus products and methods for inhibition of expression of dux4 |
| WO2013120038A2 (en) | 2012-02-10 | 2013-08-15 | Regents Of The University Of Minnesota | Morpholino targeting dux4 for treating fshd |
| CN104520324A (zh) * | 2012-02-24 | 2015-04-15 | 施特姆森特Rx股份有限公司 | Dll3调节剂及其使用方法 |
| CN104936985A (zh) * | 2013-02-26 | 2015-09-23 | 罗切格利卡特公司 | 双特异性t细胞活化性抗原结合分子 |
| DK3473270T5 (da) * | 2016-06-20 | 2024-09-09 | Genahead Bio Inc | Konjugat af antistof-lægemiddel |
| KR20240172236A (ko) * | 2017-01-06 | 2024-12-09 | 어비디티 바이오사이언시스 인크. | 핵산-폴리펩티드 조성물 및 엑손 스키핑을 유도하는 방법 |
| SG11202002517RA (en) | 2017-09-22 | 2020-04-29 | Avidity Biosciences Inc | Nucleic acid-polypeptide compositions and methods of inducing exon skipping |
| CN118638787A (zh) * | 2017-12-06 | 2024-09-13 | 艾维迪提生物科学公司 | 治疗肌萎缩和强直性肌营养不良的组合物和方法 |
| EP3830259A4 (en) * | 2018-08-02 | 2022-05-04 | Dyne Therapeutics, Inc. | MUSCLE TARGETED COMPLEXES AND THEIR USES IN THE TREATMENT OF FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY |
-
2021
- 2021-01-08 CN CN202610278622.3A patent/CN122124274A/zh active Pending
- 2021-01-08 KR KR1020227027137A patent/KR20220125801A/ko active Pending
- 2021-01-08 MX MX2022008538A patent/MX2022008538A/es unknown
- 2021-01-08 IL IL294480A patent/IL294480A/en unknown
- 2021-01-08 AU AU2021205492A patent/AU2021205492A1/en active Pending
- 2021-01-08 WO PCT/US2021/012719 patent/WO2021142275A1/en not_active Ceased
- 2021-01-08 CA CA3163299A patent/CA3163299A1/en active Pending
- 2021-01-08 JP JP2022542486A patent/JP7894315B2/ja active Active
- 2021-01-08 US US17/791,697 patent/US20230088865A1/en active Pending
- 2021-01-08 EP EP21738616.8A patent/EP4087924A4/en active Pending
- 2021-01-08 CN CN202180019466.4A patent/CN115349013B/zh active Active
- 2021-01-08 BR BR112022013603A patent/BR112022013603A2/pt unknown